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ABSTRACT
Objective: To evaluate an intervention to improve
implementation of guidelines for the prevention of
chronic vascular disease.
Setting: 32 urban general practices in 4 Australian
states.
Randomisation: Stratified randomisation of
practices.
Participants: 122 general practitioners (GPs) and
practice nurses (PNs) were recruited at baseline and
97 continued to 12 months. 21 848 patient records
were audited for those aged 40–69 years who
attended the practice in the previous 12 months
without heart disease, stroke, diabetes, chronic renal
disease, cognitive impairment or severe mental illness.
Intervention: The practice level intervention over
6 months included small group training of practice
staff, feedback on audited performance, practice
facilitation visits and provision of patient education
and referral information.
Outcome measures: Primary: 1. Change in
proportion of patients aged 40–69 years with smoking
status, alcohol intake, body mass index (BMI), waist
circumference (WC), blood pressure (BP) recorded
and for those aged 45–69 years with lipids, fasting
blood glucose and cardiovascular risk in the medical
record. 2. Change in the level of risk for each factor.
Secondary: change in self-reported frequency and
confidence of GPs and PNs in assessment.
Results: Risk recording improved in the intervention
but not the control group for WC (OR 2.52 (95% CI
1.30 to 4.91)), alcohol consumption (OR 2.19 (CI
1.04 to 4.64)), smoking status (OR 2.24 (1.17 to
4.29)) and cardiovascular risk (OR 1.50 (1.04 to
2.18)). There was no change in recording of BP,
lipids, glucose or BMI and no significant change in
the level of risk factors based on audit data. The
confidence but not reported practices of GPs and PNs
in the intervention group improved in the assessment
of some risk factors.
Conclusions: This intervention was associated with
improved recording of some risk factors but no change
in the level of risk at the follow-up audit.
Trial registration number: Australian and New
Zealand Clinical Trials Register (ANZCTR):
ACTRN12612000578808, results.
INTRODUCTION
Chronic diseases and their risk factors
account for most of the global burden of
disease.1 Nine in 10 adult Australians have at
least one of the behavioural or physiological
risk factors for chronic disease including
smoking, poor nutrition, excessive alcohol
consumption, physical inactivity, overweight
or obesity, hypertension or dyslipidemia.2
General practitioners (GPs) are well placed
to work with patients to manage these risk
factors because of their high population
Strengths and limitations of this study
▪ This is a moderately large cluster randomised
controlled trial in general practices in four
Australian states.
▪ The intervention was developed in partnership
with organisations involved in developing and
implementing guidelines for the prevention of
chronic vascular conditions in Australian general
practice.
▪ The trial design involved blind random allocation
but practitioners were not blinded to their
allocation.
▪ Although provider questionnaires relied on self-
report, medical records were electronically
audited and not subject to selection bias.
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coverage (over 80% of the population present in
primary care at least once a year), and patient accept-
ance of their role in preventive care.3 4 They are thus in
an ideal position to assess and provide advice about
lifestyle-related behavioural risk factors.5
The roles of GPs in preventive care are reinforced in
clinical guideline recommendations from a range of gov-
ernment and non-government organisations.6 7 A
number of these recommendations are based on the
‘5As’ (Ask, Assess, Advise/Agree, Assist and Arrange)
framework for a multidisciplinary preventive care.8–10
There is evidence that this approach enhances patient
motivation and behaviour change.11 Despite wide dis-
semination of preventive guidelines, implementation
barriers exist at various patient (eg, motivation and
health literacy), practitioner (eg, beliefs about effective-
ness), practice (eg, time and organisational capacity)
and system (eg, funding and workforce) levels.12–14
These barriers contribute to low rates of clinical assess-
ment of risk, lifestyle advice and referral.15–17
The Preventive Evidence into Practice (PEP) partner-
ship group developed and conducted a multicenter
cluster randomised controlled trial of a practice facilita-
tion and quality improvement intervention designed to
support general practices to implement the recommen-
dations of evidence-based clinical management guide-
lines for the prevention of cardiovascular disease (CVD)
and type 2 diabetes. This paper reports on the primary
outcome of the trial: the clinical assessment and record-
ing of patient risk factors from audited records. We
hypothesised that, for patients aged 40–69 years, the
PEP intervention would improve the recording of
patient risk factors by 20%, over 12 months.
MATERIALS AND METHODS
Design
We conducted a cluster randomised controlled trial in
urban general practices in four Australian states (New
South Wales, Victoria, South Australia and Queensland)
over 12 months (2012–2013). The methods for the PEP
trial were designed a priori, and have been described
elsewhere.15
Randomisation
Blinded practice allocation was conducted (by UJ) inde-
pendent of recruitment or data collection. Practices
were randomly assigned to intervention and control
groups after stratiﬁcation into blocks by state and prac-
tice size (the number of general practitioners in a prac-
tice) using a computer-generated randomisation list.
Participant practitioners were not blinded to allocation.
Participants
Thirty-two practices (eight from each state) were
recruited to the study through regional primary care
organisations responsible for coordinating quality
improvement activities at the local practice level. A total
of 124 practices were approached to assess their eligibil-
ity. Eighty-one declined to participate; eight did not
meet the inclusion criteria and three did not participate
for other (various reasons). Eight practices in each of
the four states provided consent.
Inclusion criteria were the use of computerised
medical records that could be audited with the PCS
Clinical Audit Tool (PENCAT) and employment of a
practice nurse (PN). PNs are registered nurses (gener-
ally bachelor degree qualiﬁed) who work in general
practice and in collaboration with GPs, coordinate and
provide preventive and chronic illness care.18
De-identiﬁed medical record data were extracted for
patients who were aged 40–69 years and had attended
the practice in the previous 12 months. Records of
patients with heart disease, stroke, diabetes or chronic
renal disease, cognitive impairment or severe mental
illness (psychoses) were excluded based on their need
for specialised assessment and management.
Intervention
The intervention was targeted at the practice level and
aimed to improve the assessment and management of
smoking; nutrition and weight; alcohol and physical
activity (SNAP),19 cardiovascular and diabetes risk;
blood pressure (BP) and lipids.
The intervention occurred over 6 months and com-
prised (1) small group training of practice staff; (2) feed-
back on audited performance; (3) a series of practice
facilitation visits; and (4) provision of patient education
resources and referral information (see box 1). The
facilitation was based on quality improvement (QI)
whereby each practice reviewed their performance and
set and reviewed goals speciﬁc to their individual
circumstances and resources. Facilitators also provided
telephone support as needed to practices over
12 months. Facilitators were sourced from a local primary
care organisation and all had expertise providing QI to
practices. Facilitators also underwent speciﬁc training to
provide the PEP intervention and were in turn supported
by the research team.
Outcomes
The primary outcomes were the assessment and record-
ing in the electronic medical record of smoking status,
alcohol use, body mass index (BMI), waist circumfer-
ence (WC), systolic and diastolic BP, fasting blood
glucose, lipids (total cholesterol, high-density lipopro-
tein, low-density lipoprotein, triglycerides) and absolute
cardiovascular (CV) risk (base on Framingham risk
score adjusted for the Australian population20).
Secondary outcomes were the self-reported assessment
practices of GPs and PNs and their conﬁdence when
performing these assessments.
Data collection
Clinicians completed a questionnaire at baseline and
12 months. This questionnaire was based on work
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previously undertaken by the investigators with questions
adapted from the Preventive Medicine Attitudes and
Activities Questionnaire (PMAAQ).21 The instrument
collected self-reported frequency of assessment of risk
factors during clinical encounters, advice given and
referral of patients identiﬁed to be at risk. We also asked
clinicians about their conﬁdence in assessing and man-
aging risk factors. Principle component analysis was per-
formed on the conﬁdence questions which identiﬁed a
single component with an Eigenvalue of 5.5 which
explained 69% of the variance.
Deidentiﬁed clinical patient data were extracted using
the PENCAT clinical audit software at baseline and
12 months. We extracted data related to recording and
level of risk factors for BMI, WC, systolic BP, alcohol and
smoking for patients aged 40–69 years and lipids, fasting
blood glucose and absolute CV risk for patients aged
45–69 years (in accordance with the guidelines).
Sample size
The sample size calculation was based on the ability to
detect an improvement of 10% between control and
intervention groups in the recording of risk factors. For
BMI with intra-cluster correlation coefﬁcient (ICC) of
0.047 at 80% power at the 5% signiﬁcance level, this
gave a sample of 8700 patient records in each group.
The same assumptions produce sample size estimates of
10 800 and 11 300 for LDL-cholesterol (ICC=0.059) and
systolic BP (ICC=0.062), respectively.
Analysis
Practice and provider characteristics at baseline were
compared between groups for those participating over
the 12 months using univariate statistical tests (χ2).
Primary analysis evaluated the change in recording of
risk factors and levels of risk factors. Levels were deﬁned
as elevated for BMI (>25), waist circumference (male
≥94 cm, female ≥80 cm), BP (>140/90), alcohol (>2
standard drinks/day), smoking (current), blood glucose
(>5.5 mmol/L), total cholesterol (>4) and CV disease
(CVD) risk (>10% over 5 years) based on evidence-based
Australian guidelines. Secondary analysis evaluated the
change in self-reported assessment and conﬁdence in
assessment by participating GPs and PNs.
Univariate statistical tests (χ2 and t tests) were per-
formed to examine difference between baseline and
follow-up, and between intervention and control partici-
pants for the outcome variables at the level of p<0.05.
Multilevel logistic regression models were used to
examine those outcomes that were signiﬁcant in the uni-
variate analysis. This modelled dichotomous dependent
variables for improvements in recording of CVD risk,
BMI, WC, alcohol, BP and smoking at follow-up. These
models examined the effect of the intervention on
improved recording of risk factors adjusted for clustering
of patients (level 1) within practices (level 2) and con-
founding effects of patient factors (age and gender) and
practice characteristics (number of GPs and nurses and
proportion of GPs/PNs working ≥10 years in primary
care).
Initially we ﬁtted a baseline variance component or
empty multilevel model (no independent variables) for
each of the dependent variables, followed by the multi-
level model with independent variables. The signiﬁcance
of the ﬁxed and random parameter variance estimates
(practice variance) was assessed using the Wald joint χ2
test statistic. The proportion of the practice level vari-
ance explained for each model was estimated as the dif-
ference in practice variance between baseline model
(empty model) and each model with independent vari-
ables divided by the practice variance for the baseline
model. All multilevel models were performed using
MLwiN V.2.25.22
Ethics and trial registration
All participants gave full informed written consent.
Clinical Trial Registration was obtained via the
Australian and New Zealand Clinical Trials Register
(ANZCTR): ACTRN12612000578808. We started the
trial registration process with ANZCTR on the 15 May
2012. We entered the CTR registration form on the 21
May 2012 and received notiﬁcation of the registration
on 29 May 2012.
Box 1 PEP Practice Intervention
1. Written feedback and practice-based discussion of clinical
record audit of recording and levels of behavioural and
physiological risk factors (BMI, waist circumference, systolic
BP, alcohol consumption, smoking status, lipids, fasting
glucose and absolute cardiovascular risk) for chronic vascular
disease from the electronic medical record of each practice.
These were compared with Australian evidence-based guide-
lines and standards.
2. Small group training (approximately 3 h duration) of all par-
ticipating general practitioners and practice nurses based on
the 5As for each of the risk factors using clinical scenarios
and case studies to reflect on assessment, advice giving, goal
setting, referral and follow-up of patients with abnormal risk
factors. There was particular emphasis on the lifestyle man-
agement of these risk factors.
3. Trained practice facilitators visited and met with practice staff
(for at least three 1–2 h) to develop and support the imple-
mentation of a plan to improve the prevention of vascular
disease in the practice population. The plan for each practice
was required to include improving the assessment and record-
ing of risk factors. Practice goals to improve other aspects of
vascular preventive care were flexibly determined for each
practice based on need and the priority of participants. There
were three structured visits over 3 months following the small
group training.
4. Patient education resources for use by practice nurses and
general practitioners and information on referral services and
programmes within the local area were provided to each prac-
tice in written and electronic form for uploading into practice
record systems. No specific prompts or templates for prevent-
ive care were used in the electronic record.
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RESULTS
Practice and provider characteristics
Of the 32 practices recruited, 16 were allocated to the
PEP intervention and 16 to usual care (ﬁgure 1). Prior
to baseline data collection, one intervention practice was
excluded because of incompatibility between the elec-
tronic medical record and the data extraction pro-
gramme and one control practice withdrew citing lack of
capacity to continue participating in the study. A further
three control practices were excluded later in the study
when technical difﬁculties impeded the collection of
audit data. The resulting sample comprised 15 interven-
tion and 12 control practices. There was no difference
between the two groups in relation to the number of
GPs in the practice (26% were solo, 30% 2–4 GPs, 44%
5 or more GPs).
There were 83 GPs and 40 PNs enrolled in the study
at baseline. At baseline 122 of the 123 practitioners
who were enrolled in the study completed the ques-
tionnaire, and 97 practitioners completed both
the baseline and follow-up questionnaires (70 GPs and
27 PNs).
There were no signiﬁcant differences between inter-
vention and control groups with respect to gender or in
the number of practices that had staff aged 55 years or
older, or those who had been working in general prac-
tice for 10 or more years. There were signiﬁcant differ-
ences in the years in general practice and years working
Figure 1. Consort flow chart. GP, general practitioners; PN, practice nurses.
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Table 1 Clinician characteristics (general practitioners and practice nurses)
Intervention
N (%)
Control
N (%)
Total
N (%)
Comparison:
intervention vs control
Gender
Female 35 (62) 23 (56) 58 (60) χ2=0.18, p=0.5
Male 21 (38) 18 (49) 39 (40)
Age (years)
20–34 7 (13) 2 (5) 9 (9) χ2=1.16, p=0.3
35–44 17 (30) 8 (20) 25 (26)
45–54 20 (36) 16 (39) 36 (37)
55–64 11 (20) 13 (32) 24 (25)
65+ 0 2 (5) 2 (2)
Missing 1 (2) 0 1 (1)
Work
Full-time equivalent 29 (52) 23 (56) 52 (54) χ2=0.06, p=0.9
Part-time equivalent 26 (46) 17 (42) 43 (44)
Missing 1 (2) 1 (2) 2 (2)
Type
Family practitioner 42 (75) 28 (68) 70 (72) χ2=0.25, p=0.6
Practice nurse 14 (25) 13 (32) 27 (28)
Years in GP
<10 27 (48) 13 (32) 40 (42) χ2=2.4, p=0.03
10–19 10 (18) 9 (23) 19 (20)
20+ 19 (34) 18 (45) 37 (38)
Years in this practice
<10 41 (74) 17 (42) 58 (60) χ2=11.0, p=0.004
10–19 8 (15) 12 (29) 20 (21)
20+ 6 (11) 12 (29) 18 (19)
GP, general practitioner.
Table 2 Proportion (%) of primary care providers self-reporting frequency of and confidence in assessments
Assessment
Intervention (n=56 baseline and
follow-up)
Control (n=41 baseline and
follow-up) Comparison
change
intervention/
control
Baseline
N (%)
Follow-up
N (%)
Per cent
change
BL to FU
Baseline
N (%)
Follow-up
N (%)
Per cent
change
BL to FU
Frequency of often, usually or always assess the risk (for more than 60% of their patients)
Diet 32 (57.1) 35 (62.5) 5.4 28 (68.3) 26 (63.5) −4.8 χ2=1.5, p=0.5
Physical activity 33 (58.9) 39 (69.6) 10.7 29 (70.7) 29 (70.7) 0 χ2=1.4, p=0.5
Smoking status 42 (75.0) 41 (73.2) −1.8 35 (85.4) 37 (90.2) 4.8 χ2=0.7, p=0.7
Alcohol use 37 (66.1) 37 (66.1) 0 27 (65.9) 30 (73.2) 7.3 χ2=1.0, p=0.6
Blood pressure 55 (98.2) 51 (91.1) −7.1 35 (85.4) 28 (92.7) 7.3 χ2=4.3, p=0.05
Fasting blood lipids 42 (75.0) 44 (78.6) 3.6 27 (65.9) 29 (70.7) 4.8 χ2=0.1, p=0.9
Fasting blood glucose 42 (75.0) 44 (78.6) 3.6 27 (65.9) 29 (68.3) 2.4 χ2=0.1, p=0.9
Body mass index 28 (50.0) 32 (57.1) 7.1 27 (65.9) 32 (78.0) 12.0 χ2=2.3, p=0.1
Absolute cardiovascular risk* 13 (23.2) 19 (33.9) 10.7 20 (48.8) 13 (31.7) −17.1 χ2=6.7, p=0.03
Proportion of providers stating that they were very confident (on a five-point scale of not at all, minimally, somewhat,
moderately and very confident)
Smoking status 23 (41.1) 32 (57.1) 17.5 19 (46.3) 18 (43.9) −2.4 χ2=3.1, p=0.08
Nutrition 12 (21.4) 17 (30.4) 9.0 13 (31.7) 10 (24.4) −7.3 χ2=0.9, p=0.3
Risky drinking 18 (32.1) 20 (35.7) 3.6 14 (34.1) 10 (24.4) −9.7 χ2=2.5, p=0.1
Physical activity 17 (30.4) 23 (41.1) 10.7 12 (29.3) 12 (29.3) 0 χ2=1.0, p=0.3
Readiness to change 8 (14.3) 16 (28.6) 14.3 9 (22.0) 5 (12.2) −9.8 χ2=5.5, p=0.04
Absolute cardiovascular risk* 16 (28.6) 25 (44.6) 16.0 16 (39.0) 13 (31.7) −7.3 χ2=5.3, p=0.03
*Australian 5-year Cardiovascular Risk based on Framingham Risk Equations modified for the Australian Population which take into account
smoking status, blood pressure, lipids, age, gender, diabetes status and Aboriginality.37
Bold indicates a statistical significant difference (p<0.05) between the amount of change from baseline to follow up in the intervention
compared with the control group.
Harris MF, et al. BMJ Open 2015;5:e009397. doi:10.1136/bmjopen-2015-009397 5
Open Access
 o
n
 3 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2015-009397 on 11 December 2015. Downloaded from 
at the enrolled practice (which was longer for the
control group; table 1).
Provider self-reported quality of care
Table 2 shows clinician self-reported frequency of, and
conﬁdence in risk factor assessment for those providers
who responded at both baseline and 12 months. At base-
line, clinicians reported frequently (often, usually or
always) assessing risk factors (except cardiovascular risk),
and there was little change at 12 months (except for
CVD risk which improved in the intervention but not
the control group; table 2). At baseline clinician conﬁ-
dence levels were low and at 12 months these had
improved in relation to the assessment of absolute CVD
risk and patient’s readiness to change (table 2).
Change in recording of risk factors at clinical record audit
From the clinical record audit, 21 848 patients aged 40–
69 years had both baseline and follow-up audit data
(73% of the total; 13 815 intervention and 8033
control). Of these, 17 565 were aged 45–69 years (10 985
and 6580 respectively). Sixty-one per cent were female
with similar proportions in the intervention and control
groups (χ2=2.7, p=0.1). At baseline the mean age overall
was 52.9 years, 52.7 years in the intervention group com-
pared to 53.2 years in the control group (t=4.28,
p<0.001).
The baseline audits of all practices identiﬁed scope
for at a least a 10% improvement in the assessment and
recording of all the risk factors except smoking which
was also signiﬁcantly higher for the control group com-
pared to the intervention group at baseline (χ2=641,
p<0.0001). In univariate analysis the proportion of
records from the intervention practices with recorded
BMI, WC, systolic BP, smoking, alcohol and CVD risk
improved over the 12-month intervention period. In the
control practices the percentage of records with waist cir-
cumference and systolic BP also improved (table 3). A
greater proportion of gaps in recording for BMI, waist
circumference, alcohol, smoking, cholesterol and abso-
lute CVD risk were ﬁlled at follow-up in the intervention
compared to the control group (table 4).
Multilevel, multivariate analyses were performed com-
paring the likelihood of a change in risk factor record-
ing (ie, where risk factors were not recorded at baseline
but were subsequently recorded at follow-up). After
adjusting for age group and gender of patients, number
of GPs and PNs in the practice and the proportion
working in the practice for 10 or more years, the likeli-
hood of change was signiﬁcantly greater in the interven-
tion compared to control group for WC (OR, 2.52 (95%
CI 1.30 to 4.91)) alcohol consumption (OR, 2.19 (CI
1.04 to 4.64)), smoking status (OR, 2.24 (1.17 to 4.29))
and cardiovascular absolute risk (OR, 1.50 (1.04 to
2.18); table 5).
Patient age increased the likelihood of an improve-
ment in recorded CVD risk and cholesterol. Younger
patients had a higher probability of waist circumference
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and BP being recorded. Smaller practices and practices
with two or more nurses were more likely to improve
assessment and recording of BP over the 12 months.
However, signiﬁcant interpractice variation remained
unexplained by the variables included in the regression
analysis (table 6).
Change in patient outcomes—clinical audit
While there was a signiﬁcant burden of ‘risk’ across the
whole audited population, where data was recorded no
signiﬁcant changes in the proportion of patients at
increased risk between baseline and follow-up were found
in either the intervention or control group (table 6).
DISCUSSION
In this multicenter cluster randomised controlled trial
the PEP intervention was associated with an improved
recording of CVD risk, WC, alcohol use and smoking
status in comparison with the control group (by between
2% and 6% for individual risk factors). Small improve-
ments in recording preventive care are consistent with
previous evaluations of practice facilitation on preventive
care23–25 underlining the challenge in achieving systemic
quality improvement. While not speciﬁcally assessed in
this trial, the failure to achieve better results with facilita-
tion may also reﬂect the variable capacity of practices to
alter their systems and routines26 27 or the perceived
importance of preventive care. Achieving greater
improvements may also require greater intervention
effort or a different approach more closely tailored to
the context of individual practice needs.26
Those older patients, who are at greater risk, were
appropriately more likely to have their CVD risk
recorded. However, they were less likely to have docu-
mented BP and WC, both of which can be readily
assessed during clinical encounters. Regular assessment
of BP is no less important in older adults28 and waist
circumference is associated with signiﬁcantly higher
mortality in the elderly after adjusting for BMI.29
We found a disparity between a high reported fre-
quency of assessments by GPs and PNs with much lower
frequency of recording in the medical record. This is
consistent with earlier research demonstrating inconsist-
ency between the frequency of self-reported assessment
and more objective measures.30 Over half of the GPs
and PNs reported not being conﬁdent in various pre-
ventive assessments at baseline, and remained so after a
year, despite some improvement in the intervention
group. This suggests the importance of developing pro-
vider skill and conﬁdence as pre-requisites for further
improvement.
The level of ‘risk’ in the patient population was high
and comparable with that reported generally for
Australians in this age group. Despite this, where
recorded, no change was found during the trial in the
proportion of patients who were at risk. This is an
important negative ﬁnding and is potentially explained
by a couple of intervention characteristics. The PEP
intervention targeted the preventive care provided by
practices and practitioners for their patients, rather than
providing new services directly to patients. The interven-
tion period was also relatively short being of 6 months
duration only. We know that effective lifestyle interven-
tions can require signiﬁcant time.23 31 There are system
barriers that may reduce the capacity of practices to
improve the frequency of referral. Barriers to referral
include patient (health literacy),32 practice (team roles
and time)33 and system level (cost and funding, informa-
tion and communication systems) factors.34 35 The impli-
cation of this may be that more direct services to
patients need to be provided in addition to practice
improvement strategies to achieve change in health
outcomes.
There are a number of limitations of our trial.
Practices were urban and thus we cannot generalise
these ﬁndings to rural or remote general practice. The
trial design did not allow blinding of practitioners to
their allocation. Practices were smaller than those par-
ticipating in a national audit of general practices)36 with
respect to size of practice (43% had four or more GPs
compared with 62.8% in the national data). All practices
in our study were urban or semiurban compared with
73.9% of those national data.
Table 4 Proportion (%) of records with missing baseline data but newly recorded risk factors at follow-up.
Intervention % (95% CI) Control % (95% CI)
Comparison of change
between intervention/control
40–69 years N=13 815 N=8033
Body mass index 9.1 (6.9 to 11.3) 7.6 (5.3 to 9.8) χ2=14,8, p<0.0001
Waist circumference 4.9 (2.8 to 7.1) 2.1 (0 to 4.2) χ2=110, p<0.0001
Systolic blood pressure 9.8 (7.6 to 12.0) 9.1 (6.8 to 11.4) χ2=2.7, p=0.1
Alcohol use 6.3 (4.1 to 8.5) 3.3 (1.1 to 5.4) χ2=95, p<0.0001
Smoking status 6.9 (4.8 to 9.1) 2.6 (0.5 to 4.8) χ2=185, p<0.0001
45–69 years N=10 985 N=6580
Cholesterol 16.4 (15.8 to 17.2) 13.5 (12.6 to 14.3) χ2=19.4, p<0.0001
Fasting blood glucose 4.5 (4.1 to 4.9) 4.6 (4.1 to 5.1) χ2=0.7, p=0.4
Absolute cardiovascular risk 14.9 (14.2 to 15.5) 8.9 (8.2 to 9.6) χ2=114, p<0.0001
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Table 5 Multilevel logistic regression models for being absent at baseline but recorded at follow-up in intervention compared to control group
CVD risk
OR (95% CI)
BMI
OR (95% CI)
Waist
circumference
OR (95% CI)
Alcohol
OR (95% CI)
Blood pressure
OR (95% CI)
Smoking
OR (95% CI)
Cholesterol
OR (95% CI)
Allocation
Control
(reference)
(n=8033)
1.0 1.0 1.0 1.0 1.0 1.0 1.0
Intervention
(n=13 815)
1.50 (1.04 to 2.18) 1.28 (0.87 to 1.88) 2.52 (1.30 to 4.91) 2.19 (1.04 to 4.64) 1.12 (0.79 to 1.58) 2.24 (1.17 to 4.29) 1.29 (0.88 to 1.91)
Patient age
<50-year
(reference)
1.0 1.0 1.0 1.0 1.0 1.0 1.0
50–59-year 1.15 (1.04 to 1.27) 0.95 (0.53 to 1.70) 0.68 (0.59 to 0.79) 1.10 (0.97 to 1.25) 0.85 (0.77 to 0.94) 0.97 (0.85 to 1.11) 1.22 (1.11 to 1.34)
>59 years 1.13 (1.01 to 1.26) 0.96 (0.85 to 1.08) 0.78 (0.66 to 0.92) 1.12 (0.97 to 1.29) 0.55 (0.49 to 0.63) 0.93 (0.80 to 1.08) 1.08 (0.97 to 1.20)
Patient gender
Male
(reference)
1.0 1.0 1.0 1.0 1.0 1.0 1.0
Female 0.99 (0.99 to 1.09) 0.96 (0.87 to 1.06) 0.94 (0.82 to 1.07) 0.98 (0.88 to 1.10) 1.04 (0.95 to 1.15) 0.93 (0.83 to 1.05) 1.06 (0.98 to 1.15)
Number of general practitioners (GP) in practice
1–3 GPs
(reference)
1.0 1.0 1.0 1.0 1.0 1.0 1.0
>3 GPs 0.89 (0.58 to 1.37) 1.16 (0.78 to 1.72) 1.64 (0.75 to 3.59) 1.95 (0.81 to 4.68) 0.64 (0.43 to 0.96) 1.06 (0.54 to 2.06) 0.86 (0.54 to 1.35)
Number of practice nurses (PN) in practice
1or less PN
(reference)
1.0 1.0 1.0 1.0 1.0 1.0 1.0
>1 PN 1.51 (0.99 to 2.31) 1.28 (0.87 to 1.88) 1.32 (0.62 to 2.82) 0.83 (0.36 to 1.96) 1.61 (1.08 to 2.40) 0.92 (0.48 to 1.76) 1.35 (0.87 to 2.11)
Percentage of GPs/PNs working in primary care >10 years
0 (reference) 1.0 1.0 1.0 1.0 1.0 1.0 1.0
>0 or more 0.72 (0.37 to 1.40) 1.02 (0.55 to 1.88) 1.01 (0.30 to 3.36) 0.90 (0.24 to 3.41) 0.55 (0.30 to 1.03) 0.41 (0.15 to 1.14) 1.34 (0.67 to 2.71)
Between
practice
variance (SE)
0.201 (0.062) 0.159 (0.051) 0.640 (0.197) 0.869 (0.251) 0.174 (0.054) 0.482 (0.145) 0.231 (0.069)
Percentage of
Variance
explained*
14.8 32.3 46.9 33.1 11.7 0 37.2
Proportion of GPs/PNs working in primary care >10 years included as a continuous variable.
*Explained ‘between practice’ variance using the variance in the baseline model as reference.
Bold indicates a statistically significant difference (p<0.05) in the OR for the independent variable compared with its reference variable.
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Although largely comparable, there were some differ-
ences at baseline in practitioner years in general practice
and in their current practice between intervention and
control groups. Furthermore there were differences at
baseline in the recorded frequency of smoking which
made it more difﬁcult to show improvement in this risk
factor the control group. In addition, the provider ques-
tionnaire relied on self-report and as such was subject to
recall and social desirability bias. While all practitioners
agreed to the assessment goals, the implementation of
the intervention with patients was constrained by their
lack of conﬁdence and other practical constraints. The
number of practitioners was too small for multilevel ana-
lysis of their self-reported data.
The sample size was lower in the control practices due
to the smaller number of practices and practitioners and
thus it was insufﬁciently powered to show a 10% or less
difference in BP and cholesterol recording between
intervention and control practices. Patient medical
record audits did not allow examination of other patient
characteristics such as health literacy and did not allow
for the measurement of assessments that had
been recorded in other ways by the GP. Only a minority
of the interpractice variance in CVD risk, BMI and BP
recording was explained by variables included in the
regression model suggesting that other factors need to
be explored.
CONCLUSION
The PEP intervention involved clinical audit, provider
training, practice facilitation visits and linkage to other
services. It had a positive impact on provider behaviour,
as evidenced by the improved assessment and recording
of smoking, WC, alcohol and absolute CVD risk.
Effective implementation of preventive care in PHC is
however a complex iterative process that requires
ongoing support and monitoring at the patient, pro-
vider, practice and system levels. This result is extremely
relevant to the role of primary care organisations in
Australia which are charged with improving the quality
of care. Our trial did however show no impact on
patient risk. Achieving the latter may require more
intensive facilitation over a longer time frame, changes
to the electronic medical record to prompt preventive
care, additional support of practices to make changes to
their work ﬂow and providing interventions that directly
involve patients (such as telephone or online coaching).
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